Virtual Self-Management Program for JIA
Feasibility and Acceptability of a Virtual Self-management Program - A Pilot Randomized Controlled Trial for Adolescents With Juvenile Idiopathic Arthritis
University of Calgary
100 participants
Dec 13, 2023
INTERVENTIONAL
Conditions
Summary
The aim of this project is to conduct a pilot randomized controlled trial (RCT) to evaluate the feasibility and preliminary effectiveness of a virtual group based self-management program (SMP) in adolescents with JIA across different provinces compared to a wait-list control group receiving only standard of care. Participants in the SMP group will partake in four 60-90 minute group sessions conducted over 8 weeks. The intervention is a multifaceted program that includes JIA disease education, self-management strategies, and peer support. Both the interventional and control group will be asked to complete baseline and post-test measures. Participants in the control group will be offered the SMP after completion of the post-control outcome measures.
Eligibility
Inclusion Criteria5
- Adolescents between the ages of 12 and 17
- Confirmed diagnosis within 2 years according to the International League of Associations for Rheumatology JIA classification criteria (2)
- Followed in one of the pediatric rheumatology clinics participating in the RCT
- Able to access the Internet on a computer
- Willing and able to complete online measures
Exclusion Criteria4
- Insufficient English reading and speaking skills
- Untreated psychiatric or comorbid disorders or major cognitive impairments leading to inability to understand materials and participate in the SMP group activities.
- Other chronic conditions such as other autoimmune disease, neurologic, orthopedics or other systems disorder (e.g. heart, kidney) that might influence outcome assessments
- Past participation in the last year or participating in another peer-support or self-management program
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Four sessions, 60-90 minutes each, will be conducted over eight weeks with a group size of 4-6 participants via videoconferencing platforms such as Zoom or Microsoft Teams. Each session will include Power Point delivered presentations, interactive activities, and group discussions. This is a multifaceted program that includes JIA disease education, self-management strategies, and peer support.
No intervention. Participant only receives standard of care.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06184100